Oczyesa

Medicinal product

(Invented) name

Oczyesa

Active substance (s)

Oktreotidas

Strength

20 mg

Pharmaceutical form

pailginto atpalaidavimo injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

H01CB02, Octreotide

Marketing authorisation holder

Camurus AB, Švedija

Date of authorisation

2025-06-30

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Užpildytame švirkštiklyje (1 ml tirpalo) yra	1 ml
Oktreotidas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117912	104017	1104017	užpildytas švirkštiklis	1 ml N1		Receptinis	EU/1/25/1938/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-30	Registruotas